Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents

Istanbul University - Cerrahpasa (IUC)

Status

Enrolling

Conditions

Obese

Exercise Capacity

Adolescent Obesity

Child Obesity

Treatments

Other: assessment study

Study type

Observational

Funder types

Other

Identifiers

NCT05392920

2022/37

Details and patient eligibility

About

Obese individuals need to be evaluated comprehensively before exercise programs are determined. Determination of exercise intolerance is important for the detection of functional limitations. One minute sit to stand test (1MSTST) can be used as an alternative to cardiopulmonary exercise tests (CPET) or field tests. It is easy to use, quick to apply, valid and reliable, and applicable even in small areas. In addition, it is a simple assessment adequate for children's needs and behaviors and can be easily applied both in the clinic and at home, making it easier to use in children. Studies have shown that 1MSTST is a valid test in chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease, and, healthy children and adolescents. However, no study has been found regarding the validity of its use in obese children and adolescents.The aim of our study is to investigate the validity and reliability of 1MSTST in overweight-obese children and adolescents.

Enrollment

28 estimated patients

Sex

All

Ages

8 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Being in the 8-18 age range.
Being overweight (between 85 and 95 according to the Body Mass Index percentile).
Being obese (over 95 based on the Body Mass Index percentile).
Not doing any vigorous exercise two hours before the test.

Exclusion criteria

History of hospitalization in the last month for a reason that may affect physical performance.
Having neurological, musculoskeletal disease that prevents exercise tests.
Uncontrollable medical conditions (Cardiovascular, pulmonary disease, etc.).
Visual and/or vestibular disorders.